BACKGROUND: The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. METHODS: From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis. RESULTS: Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor (P = .040). CONCLUSIONS: Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancer patients appears to be a safe and effective treatment, especially in pCR patients.
BACKGROUND: The aim of the current study was to evaluate the clinical availability of local excision (LE) for advanced rectal cancer without lymph node metastasis after neoadjuvant chemoradiation therapy (nCRT) in Korea. METHODS: From June 2000 to October 2009, 40 patients with cT2-3N0M0 rectal cancer underwent nCRT followed by LE according to a retrospective multicenter analysis. RESULTS: Of the 40 patients, 22 were men and 18 were women. Eighteen patients were cT2, and 22 patients were cT3. The median follow-up duration was 38 months. Three patients (7.5%) had morbidity after LE. Four patients (10%) had recurrence (local recurrence [1 patient] and systemic metastasis [3 patients]). The 3-year disease-free survival rate was 85.9%. Only pCR was a recurrence-related prognostic factor (P = .040). CONCLUSIONS: Although the current study was not a randomized controlled study, LE after nCRT in T2-3N0 rectal cancerpatients appears to be a safe and effective treatment, especially in pCR patients.
Authors: C Pericay; X Serra-Aracil; J Ocaña-Rojas; L Mora-López; E Dotor; A Casalots; A Pisa; E Saigí Journal: Clin Transl Oncol Date: 2015-10-26 Impact factor: 3.405
Authors: Marco Armbruster; Melvin D'Anastasi; Veronika Holzner; Martin E Kreis; Olaf Dietrich; Bernhard Brandlhuber; Anno Graser; Martina Brandlhuber Journal: Int J Colorectal Dis Date: 2018-05-17 Impact factor: 2.571
Authors: Xavier Serra-Aracil; Laura Mora-Lopez; Manel Alcantara-Moral; Aleidis Caro-Tarrago; Carlos Javier Gomez-Diaz; Salvador Navarro-Soto Journal: World J Gastroenterol Date: 2014-09-07 Impact factor: 5.742
Authors: Young Seob Shin; Yong Sik Yoon; Seok-Byung Lim; Chang Sik Yu; Tae Won Kim; Heung Moon Chang; Jin-Hong Park; Seung Do Ahn; Sang-Wook Lee; Eun Kyung Choi; Jin Cheon Kim; Jong Hoon Kim Journal: Radiat Oncol J Date: 2016-09-28
Authors: Sungwoo Jung; Anuj Parajuli; Chang Sik Yu; Seong Ho Park; Jong Seok Lee; Ah Young Kim; Jong Lyul Lee; Chan Wook Kim; Yong Sik Yoon; In Ja Park; Seok-Byung Lim; Jin Cheon Kim Journal: Ann Coloproctol Date: 2019-10-31
Authors: Sung Min Jung; Chang Sik Yu; In Ja Park; Tae Won Kim; Jong Hoon Kim; Yong Sik Yoon; Seok-Byung Lim; Jin Cheon Kim Journal: Medicine (Baltimore) Date: 2016-05 Impact factor: 1.889